Back to Search

UTHR

United Therapeutics Corp
Data: 2026-11-11
$595.66
Price
1.50%
Change
$614.23
52W High
$449.58
52W Low
Full AI Analysis Buy/Sell Forecast Trendline Why Moving Charts Options
Analyzing positioning… Options positioning — based on yesterday's biggest open-interest changes See the chart Institutional flows
Track record
signal day → next-day price move
Quick Stats
Nov 11, 2026

51.6

AI Score

HOLD

0.45

Volume Ratio

TBA

Next Earnings

19

+ve Days (30d)

11

-ve Days (30d)

UTHR Price vs Max Options Open Interest

How to read this: the line is the stock price; the bars show where the most option open interest sits each day. Strikes with heavy open interest often act as magnets or barriers for price ("max pain" zones). Scroll right for the most recent days.

UTHR Max Change In Options Open Interest

How to read this: each bar is the option contract whose open interest changed the most yesterday. Green bars = new positions being opened (conviction building at that strike); red bars = positions being closed. Call builds above the current price suggest upside bets; put builds below it suggest hedging or downside bets.

UTHR Options - Sort by Max open Interest (near term)

12th November 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

UTHR Daily Out of Money Options - Sort by Max open Interest (near term)

12th November 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

UTHR Daily In the Money Options - Sort by Max open Interest (near term)

12th November 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

UTHR Most Active Options by Volume(near term)

12th November 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI		 Ask PC Delta Vega Volatility % change Track
UTHR Technical Chart Pro Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select an indicator above — it will be added as a pane under the price chart with aligned dates.

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

UTHR Stock Summary

Last updated Nov 11, 2026

UTHR is currently trading at $595.66, positioned above its 200-day moving average of $536.22, indicating a long-term uptrend. The stock has a 52-week range of $449.58 to $614.23.

Technical Analysis: The 50-day moving average stands at $538.59, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 60.114, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.131, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates UTHR at 51.6/100 with a HOLD recommendation.

UTHR (United Therapeutics Corp) Indicators

Last updated Nov 11, 2026

Indicator Value
RSI(14) 60.114
CMF (20) 0.131
ROC (10) 1.565
ADX (14) 20.276
Indicator Value
MACD (12,26,9) 13.445
AROONOSC (14) -21.429
WILLAMS %R (14) -32.24
MFI (14) 55.278

UTHR Candlestick Patterns

No validated candlestick patterns fired for UTHR in the last 10 sessions — that's normal. Only the ~15 patterns with a backtested edge (out of 60 textbook patterns) are tracked here.

United Therapeutics Corp is above both the 50 Day and 200 Day SMA which is considered Bullish.

UTHR Moving Averages Analysis

United Therapeutics Corp has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Nov 11, 2026

United Therapeutics Corp has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Nov 11, 2026

UTHR (United Therapeutics Corp) Simple Moving Averages

Moving Averages are last updated Nov 11, 2026

Days MA
10 589.45
20 578.62
30 567.47
50 538.59
100 533.82
200 536.22

UTHR Fundamental Analysis

P/E (Forward) 18.4502
P/E (Trailing) 22.2201
Market Cap ($) 25.1 billion
Earnings/Share ($) 26.49
Net Profit Margin (%) 0.3861
Dividend/Share ($) --
EPS Estimate Current Year ($) 24.756
EPS Estimate Next Year ($) 31.5435
WallStreet Target Price ($) 687.14
Most Recent Quarter

United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. In addition, it is developing a pipeline of projects that includes new indications and delivery devices for existing products and new products to treat PAH and other conditions.